Target Price | JPY663.00 |
Price | JPY983.00 |
Deviation |
32.55%
register free of charge
|
Number of Estimates | 9 |
9 Analysts have issued a price target Sumitomo Dainippon Pharma 2026 .
The average Sumitomo Dainippon Pharma target price is JPY663.00.
This is
32.55%
register free of charge
JPY1,260.00
28.18%
register free of charge
JPY434.30
55.82%
register free of charge
|
|
A rating was issued by 14 analysts: 1 Analysts recommend Sumitomo Dainippon Pharma to buy, 6 to hold and 7 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Sumitomo Dainippon Pharma stock has an average upside potential 2026 of
32.55%
register free of charge
|
Mar '25 |
2026 Estimates |
|
---|---|---|
Revenue Billion JPY | 398.83 | 377.47 |
26.79% | 5.36% | |
EBITDA Margin | 13.86% | 20.60% |
130.72% | 48.65% | |
Net Margin | 5.93% | 7.32% |
105.92% | 23.53% |
9 Analysts have issued a sales forecast Sumitomo Dainippon Pharma 2026 . The average Sumitomo Dainippon Pharma sales estimate is
This results in the following potential growth metrics:
8 Analysts have issued an Sumitomo Dainippon Pharma EBITDA forecast 2026. The average Sumitomo Dainippon Pharma EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
9 Sumitomo Dainippon Pharma Analysts have issued a net profit forecast 2026. The average Sumitomo Dainippon Pharma net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Mar '25 |
2026 Estimates |
|
---|---|---|
Earnings Per Share JPY | 59.49 | 69.50 |
107.50% | 16.83% | |
P/E | 14.14 | |
EV/Sales | 1.67 |
9 Analysts have issued a Sumitomo Dainippon Pharma forecast for earnings per share. The average Sumitomo Dainippon Pharma EPS is
This results in the following potential growth metrics and future valuations:
Sumitomo Dainippon Pharma...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.